中国神经再生研究(英文版) ›› 2026, Vol. 21 ›› Issue (8): 3462-3478.doi: 10.4103/NRR.NRR-D-25-00710

• 综述:退行性病与再生 • 上一篇    下一篇

铁死亡可诱发衰老相关神经退行性疾病

  

  • 出版日期:2026-08-18 发布日期:2026-04-25
  • 基金资助:
    国家自然科学基金(81101462)的支持; 中国国家重点研发计划(2020YFC2005700);辽宁省自然科学基金(201602875、2019-KF-01-06); 辽宁省重点研发计划项目(2024JH2/102500021);辽宁省自然科学基金项目(2022-YGJC-56)

Ferroptosis and aging: Inducing and catalyzing neurodegenerative diseases

Qifeng Song1, 2, #, Shi Sun1, #, Yuxiu Song1, Yashi Wang1, Yin Yuan1, Lixin Zhang1, *, Qian Cui1, *   

  1. 1Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China; 
    2Department of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China
  • Online:2026-08-18 Published:2026-04-25
  • Contact: Lixin Zhang, PhD, uzhanglx@aliyun.com; Qian Cui, PhD, phoenixcq2020@163.com.
  • Supported by:
    This work was supported by the National Natural Science Foundation of China, No. 81101462 (to LZ); the National Key Research and Development Program of China, No. 2020YFC2005700 (to LZ); the Natural Science Foundation of Liaoning Province, China, Nos. 201602875, 2019-KF-01-06 (both LZ); Key Research and Development Program of Liaoning Province, China, No.  2024JH2/102500021 (to LZ); the Natural Science Foundation of Liaoning Province, China, No.2022-YGJC-56 (to SS).

摘要:

铁死亡是一种新近确认的程序性细胞死亡形式,其特征为依赖于铁过载的脂质过氧化,这些病理现象常出现在神经退行性疾病中。衰老是组织和细胞功能不可逆退化的过程,已被证实会引发神经退行性疾病并增加对铁死亡的易感性。因此,铁死亡可能作为致病因素参与神经退行性疾病的进展,而衰老是两者共同的催化剂。此综述的目的是阐述铁死亡诱发衰老相关神经退行性疾病的最新进展,包括铁过载、脂质过氧化与抗氧化防御、细胞膜修复、自噬调控及转录因子调控。文章还探讨了铁死亡与衰老之间的关系,并报告称衰老可通过增加铁过载、增强脂质过氧化及加剧自噬紊乱来诱导铁死亡。鉴于铁死亡是神经退行性疾病的致病因素,文章筛选了基因库数据库,发现与铁死亡和神经退行性疾病相关的许多基因相互重叠,且与过氧化数据库和铁死亡通路相关的基因均呈现富集现象。铁死亡发生于与年龄相关的铁积累和脂质富集、自噬水平及转录因子紊乱的条件下,作为诱发神经退行性疾病发生的致病因素。此外,在各种神经退行性疾病中,某些特定的病理变化或疾病产物也可能促进铁死亡的发生。最后,基于铁死亡抑制剂、物理疗法、干细胞和外泌体疗法在神经退行性疾病中的动物研究和临床试验发现,抑制铁死亡可有效逆转神经退行性疾病后的神经功能障碍和认知障碍。然而,受各种限制因素影响,部分动物研究和临床试验的结果并不理想,仍需进一步开展大规模研究。综上,铁死亡诱发了衰老相关神经退行性疾病和神经元细胞死亡形式,并触发疾病发作和进展。铁死亡抑制剂、物理疗法、干细胞和外泌体疗法在神经退行性疾病中抑制铁死亡具有广阔前景。


https://orcid.org/0000-0003-1421-9612 (Lixin Zhang); https://orcid.org/0009-0007-2490-5137 (Qian Cui)

关键词: 衰老, 阿尔茨海默病, 帕金森病, 外泌体, 铁死亡, 铁过载, 脂质过氧化, 物理疗法, 干细胞, 神经再生

Abstract: Ferroptosis is a newly recognized form of programmed cell death characterized by iron overload-dependent lipid peroxidation. These pathological phenomena are often observed in neurodegenerative diseases. Aging is an irreversible process characterized by the deterioration of tissue and cell function. It has been shown to contribute to neurodegenerative diseases and increase susceptibility to ferroptosis. Therefore, ferroptosis may be involved in the progression of neurodegenerative diseases as a pathogenic factor, and aging is the common catalyst of both processes. The purpose of this review is to elucidate the latest progress on the mechanisms related to ferroptosis in neurodegenerative diseases, including iron overload, lipid peroxidation, antioxidant defense, cell membrane repair, and the regulation of autophagy and transcription factors. We also explored the relationship between ferroptosis and aging and reported that aging can induce ferroptosis by increasing iron overload, enhancing lipid peroxidation, and exacerbating autophagy disorders. Since ferroptosis is a pathogenic factor in neurodegenerative diseases, we screened gene bank databases and found that many genes associated with ferroptosis and neurodegenerative diseases overlap. Additionally, genes related to both the peroxidation pathway and ferroptosis are enriched. Ferroptosis occurs under conditions of age-related iron accumulation and lipid enrichment, as well as due to disorders in autophagy levels and transcription factors. Furthermore, in various neurodegenerative diseases, specific pathological changes or products can also contribute to the occurrence of ferroptosis. Finally, based on animal studies and clinical trials involving ferroptosis inhibitors, physical therapies, stem cell treatments, and exosome therapies in neurodegenerative diseases, it has been found that inhibiting ferroptosis can effectively reverse neurological dysfunction and cognitive impairment associated with these conditions. However, given various limitations, the conclusions of some animal studies and clinical trials have not been ideal, indicating that further large-scale research is necessary. Taken together, ferroptosis induces aging-related neurodegenerative diseases and neuronal cell death, triggering disease onset and progression. Ferroptosis inhibitors, physical therapies, stem cell treatments, and exosome therapies show great potential for inhibiting ferroptosis in neurodegenerative disease. 

Key words: aging, Alzheimer’s disease, exosomes, ferroptosis, iron overload, lipid peroxidation, neural regeneration, Parkinson’s disease, physical therapy, stem cells